Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Ordinary Shares, par value $0.000174 per share
-
Shares outstanding
-
55,803,824
-
Total 13F shares
-
10,919,115
-
Share change
-
-148,715
-
Total reported value
-
$10,918,005
-
Price per share
-
$1.00
-
Number of holders
-
15
-
Value change
-
-$44,044
-
Number of buys
-
3
-
Number of sells
-
9
Institutional Holders of Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share (CNTB) as of Q1 2023
As of 31 Mar 2023,
Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share (CNTB) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,919,115 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., Kynam Capital Management, LP, UBS OCONNOR LLC, Ikarian Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, JPMORGAN CHASE & CO, BOOTHBAY FUND MANAGEMENT, LLC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
15
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.